Make your voice heard! You can have an impact on the U.S. Drug Enforcement Administration’s proposal to reschedule marijuana from a Schedule I drug to a Schedule III drug under the Controlled Substances Act by providing comment to the NPRM. The deadline for submitting...
Reprinted article courtesy of Quest Diagnostics, a leading provider of diagnostic information services. Key Findings The overall drug positivity held steady at historically high rates in 2023, while marijuana positivity continued an upward climb in the general U.S....
Rescheduling marijuana to Schedule III will prevent the U.S. Department of Transportation from prohibiting active use for those in transportation safety positions. Without a safety carveout - or a clear plan to prevent this unintended consequence, the traveling public...
By Dr. Jonathan Baktari, MD, CEO of US Drug Test Centers Supporting teamwork and employee training are crucial aspects of running a successful business. When employees work well together, they can achieve more than they could individually. Teamwork involves...
The substance abuse epidemic continues across the United States, with one in four Americans reporting that they have used illicit drugs. According to the 2022 United States National Survey on Drug Use and Health (NSDUH): 46.8 million (16.7%) Americans (aged 12 and...
Courtesy of American Substance Abuse Professionals AP News reports that the US Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug. Reclassifying marijuana as a less dangerous drug creates medical and...
Since 1949, the United States has observed May as Mental Health Awareness Month. The workplace is a key venue for promoting mental wellness and awareness about when and how to help someone who is experiencing emotional distress. In recognition of Mental Health...
The drug and alcohol testing industry needs your expertise and insights – and NDASA hopes you will share them in upcoming issues of its e-magazine! For the summer issue, let us know you want to be included by May 15. The final submission deadline for all content is...
By Dr. Jonathan Baktari, MD, CEO of US Drug Test Centers The entrepreneurial bug bit me at a young age, and becoming a doctor and medical director only amplified that drive. Working in medicine, I witnessed firsthand a severe lack of accessibility to healthcare. This...
By Patrice M. Kelly, JD, Senior Policy Executive Advisor Many of you have heard me say, “My favorite hour each week is the NDASA Town Hall meeting time!” I genuinely mean that. Where else can you find relevant and clear advice in an engaging format open to questions...